The hypothesized role of an increase in kinase activity of LRRK2 in cancer development, if confirmed via in vitro studies, potentially paves the way for the use of small molecule LRRK2 inhibitors beyond PD: LRRK2-amplificated cases are putative candidates for such treatment. Here, LRRK2 is linked to cancer.